Summary of SYNUTRA INTERNATIONAL, INC.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

Sections of this Quarterly Report on Form 10-Q (the "Form 10-Q") including, in particular, the Company's Management's Discussion and Analysis of Financial Condition and Results of Operations contain forward-looking statements. These forward-looking statements are not guarantees of future performance and are subject to certain risks, uncertainties and assumptions that are difficult to predict; therefore, actual results may differ materially from those expressed, implied or forecasted in any such forward-looking statements.

Expressions of future goals and expectations or similar expressions including, without limitation, "may," "should," "could," "expects," "does not currently expect," "plans," "anticipates," "intends," "believes," "estimates," "predicts," "potential," "targets," or "continue," reflecting something other than historical fact are intended to identify forward-looking statements. The factors described in the Company's Annual Report on Form 10-K under Part I. Item 1A. Risk Factors and below in Part II. Other Information - Item 1A. Risk Factors could cause the Company's actual results to differ materially from those described in the forward-looking statements. Unless required by law, the Company undertakes no obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise. However, readers should carefully review the reports and documents the Company files from time to time with the SEC, particularly its Quarterly Reports on Form 10-Q, Annual Report on Form 10-K , Current Reports on Form 8-K and all amendments to those reports.

Available Information

The Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and amendments to reports filed pursuant to Sections 13(a) and 15(d) of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), are filed with the SEC. Such reports and other information filed by the Company with the SEC are available on the Company's website at http://www.synutra.com when such reports are available on the SEC website. The public may read and copy any materials filed by the Company with the SEC at the SEC's Public Reference Room at 100 F Street, NE, Room 1580, Washington, DC 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The SEC maintains an Internet site that contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC at http://www.sec.gov. The contents of these websites are not incorporated into this filing. Further, the Company's references to the URLs for these websites are intended to be inactive textual references only.

OVERVIEW

We are a leading infant formula company in China. We principally produce, market and sell our products under "Sheng Yuan," or "Synutra," our master brand, and several sub-brands, including "Super," "U-Smart" and "U-Strong." We focus on selling premium infant formula products, which are supplemented by more affordable infant formulas targeting the mass market as well as other nutritional products and ingredients. We sell our products through an extensive nationwide sales and distribution network covering 29 provinces and provincial-level municipalities in China. As of September 30, 2008, this network comprised over 430 distributors and over 1,200 sub-distributors who sell our products in over 70,000 retail outlets. Our extensive sales, and distribution network, combined with our strong customer service and infant nutrition education programs, has helped us build brand recognition and customer loyalty in our primary markets, which, prior to 2007, mainly comprised small to mid-size cities and rural areas in China. By leveraging our strong brand recognition in our primary markets, we have begun to expand into many of China's major urban centers, which have historically been dominated by several large multinational firms.

We have opportunistically utilized excess capacity and resources to provide toll packaging services, toll drying services, and sales of ingredients and materials to industrial customers. These businesses, however, are not our core businesses and do not contribute significantly to our results of operations.

On September 16, 2008, we announced a compulsory recall on certain lots of our U-Smart products and a voluntary recall on all other products that used milk supplied from the regions of Hebei and Inner Mongolia which include U-Smart, U-Strong, adult formula products and rice powder products.

The compulsory recall was due to the fact that certain lots of our U-Smart series of products have been contaminated by melamine, a substance not approved for use in food and linked to recent illness among infants and children in China. We have completed the recall of all eight lots of our U-Smart products that were found to be contaminated with melamine following testing by the Chinese government.

We believe that the melamine contamination resulted from tainted milk supplies provided by third-party suppliers in the Hebei and Inner Mongolia regions. As a result we made the voluntary recall on all other products that use milk supplied from these regions which include U-Smart, U-Strong, adult formula products and rice powder products, produced before September 16, 2008. In addition, out of an abundance of caution, we also recalled certain Stage 4 Super products, although no Super products have been found to be contaminated with melamine. The Company has substantially completed the voluntary recall of all of the products identified above.

The estimated cost of the product recall is $77.4 million which has been recognized as a charge to cost of sales and selling and distribution expenses in our consolidated statement of income for the fiscal quarter ended September 30, 2008, of which $38.0 million was recorded as a product recall provision in our consolidated balance sheet as of September 30, 2008. This amount includes the replacement cost of the recalled products of $36.0 million, write-down and write-off of affected inventory of $39.5 million, and logistical expenses associated with the recall of $1.9 million. These costs represent our estimate of probable costs based on available data and take into account factors such as expected return rates for the affected units, unit replacement costs, logistical expenses and expenses relating to the hiring of temporary contractors to assist with our recall efforts. Should actual product recall costs differ from the estimated costs, we will have to reassess the negative impact of the product recall on our financial results and revise the estimated product recall accrual accordingly.

Our product recall does not involve any cash pay-out to our distributors or customers. Rather, both distributors and customers receive new products of the same value in exchange for recalled products. Since the product recall was ongoing during both our second and third fiscal quarters, the recall will negatively impact our financial results for the third fiscal quarter and result in a significant reduction of revenue for such quarter as products shipped during such quarter will be used to replace recalled products. We cannot, however, determine the extent and scope of such impact on our financial results for the quarter ending December 31, 2008 at this time.

We do not anticipate that the product recall will negatively impact our results for the fiscal quarter ending March 31, 2009 or subsequent fiscal quarters, although we currently cannot provide any assurance in this regard. Although management is not aware of any additional significant issues associated with the melamine contamination incident, there can be no assurance that additional issues will not be identified in the future and this may have an adverse effect on our results of operations. See Part II. Other Information - Item 1A. Risk Factors - We are highly dependent upon consumers' perception of the safety and quality of our products as well as similar products distributed by other companies in our industry, particularly as they relate to the health and safety of infants and children. Any ill effects, product liability claims, recalls, adverse publicity or negative public perception regarding particular ingredients or products or our industry in general, or stemming from contamination of our products, or counterfeiting or other substandard imitations, could harm our reputation and damage our brand, result in costly and damaging recalls and government sanctions and possibly litigation and materially and adversely affect our results of operations.

Since the beginning of October 2008, all of our manufacturing facilities have been returned to service, after passing government inspections and obtaining permission from governing authorities. We continue to comply with random and unscheduled government testing and to conduct enhanced and systematic testing in-house.

In order to regain customer confidence and to ensure products of the highest quality, we are now using imported milk powder from Europe and New Zealand in our U-Smart series products. Through our network of distributors, we have restocked 90% of our contracted shelf space nationwide with new U-Smart series products and Super series products produced after October 1, 2008. All such products have been found free of melamine and compliant with various government tests.

In late October 2008, we launched an entirely new series of infant formula products, the "Mingshan" series, aimed at the expansive lower and mid-tier Chinese markets. We expect shipments of Mingshan series products to reach our sales network in December 2008.

Due to the melamine contamination incident that hit China's infant formula industry in mid September, our net sales for the fiscal quarter ended September 30, 2008 increased only slightly by 10.0% to $94.8 million from $86.2 million for the same period in the previous year. Our gross loss for the fiscal quarter ended September 30, 2008 was $26.7 million, as compared to gross profit of $46.6 million for the same period in the previous year. Our net loss for the fiscal quarter ended September 30, 2008 was $49.7 million, as compared to net income of $9.8 million for the same period in the previous year.

Our net sales for the six months ended September 30, 2008 increased by 44.6% to $222.2 million from $153.7 million for the same period in the previous year. Our gross profit for the six months ended September 30, 2008 decreased by 52.0% to $40.2 million from $83.7 million for the same period in the previous year. Our net loss for the six months ended September 30, 2008 was $34.0 million, as compared to net income of $15.1 million for the same period in the previous year.

The net loss for the three and six month periods ended September 30, 2008 compared to the same periods last year is attributable primarily to the estimated cost of product recall and decreased sales in the second half of September as a result of the melamine contamination incident.

CRITICAL ACCOUNTING POLICIES

We follow certain significant accounting policies when preparing our consolidated financial statements. A summary of these policies is included in our Annual Report on Form 10-K for the year ended March 31, 2008 (Form 10-K). The preparation of these financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and judgments that affect our reported amounts of assets, liabilities, revenues and expenses, and the related disclosures of contingent assets and liabilities at the date of the financial statements. We evaluate these estimates and judgments on an ongoing basis and base our estimates on historical experience, current conditions and various other assumptions that are believed to be reasonable under the circumstances. The results of these estimates form the basis for making judgments about the carrying values of assets and liabilities as well as identifying and assessing the accounting treatment with respect to commitments and contingencies. Our actual results may differ from these estimates.

We believe that the estimates, assumptions and judgments involved in the accounting policies described in the "Management's Discussion and Analysis of Financial Condition and Results of Operations" section of our most recent Annual Report on Form 10-K have the greatest potential impact on our financial statements, so we consider these to be our critical accounting policies.

Additionally, in response to the melamine contamination incident, we have established an accounting policy for the product recall. We consider our policy of product recall provision to be a critical accounting policy due to the significant level of estimates, assumptions and judgment and its potential impact on our consolidated financial statements. We have included below a description of our accounting policy for product recall provision.

Product Recall

We establish a reserve for product recall on a product-specific basis when circumstances giving rise to the recall become known. Facts and circumstances related to the recall, including where the product affected by the recall or withdrawal is located (e.g., with consumers, in customers' inventory, or in the Company's inventory), the expected product return rates by our distributor and end-customers, cost estimates for shipping and handling for returns and estimated replacement costs are considered when establishing a product recall reserve. These factors are updated and reevaluated each period and the related reserves are adjusted when these factors indicate that the recall reserve is either not sufficient to cover or exceeds the estimated product recall expenses.

RESULTS OF OPERATIONS

Three months ended September 30, 2008 and 2007

Net Sales

Net sales for the three months ended September 30, 2008 increased by 10.0% to $94.8 million from $86.2 million for the same period in the previous year. This slight increase in net sales was a combined result of increased sales in July and August 2008, partially offset by decreased sales in September 2008 due to the disruption of our operations caused by the melamine contamination incident.

Net sales of our nutritional products, including infant formula and other nutritional products for children and adults under our Super, U-Smart, and U-Strong brand names, accounted for 89.8% of our total sales for the fiscal quarter ended September 30, 2008. Net sales of our nutritional products for the fiscal quarter ended September 30, 2008 increased by 12.9% to $85.2 million from $75.4 million for the same period in the previous year, primarily as a result of the following factors:

n Sales volume of nutritional products decreased by 8.1% to 8,798 tons for the fiscal quarter ended September 30, 2008 from 9,569 tons for the same period in the previous year because of decreased sales in the second half of September as a result of the melamine contamination incident.

n The average selling price of our nutritional products for the fiscal quarter ended September 30, 2008 increased by 22.8% to $9,680 per ton from $7,883 per ton for the same period in the previous year. This increase in average selling price was primarily due to an increase in sales of Super infant formula products, which resulted in a greater proportion of higher-priced products in our product mix.

As we anticipate that products shipped during the third fiscal quarter will be used to replace the recalled products, and since the damage to our reputation caused by the melamine contamination incident will take time to recover, we expect the net sales of our nutritional products to be negatively impacted in the fiscal quarter ending December 31, 2008 although the extent and scope of such negative impact on net sales cannot be determined at this time.

Net sales from our other activities, such as sales of industrial materials and the provision of certain services, such as toll drying, blending and packaging services, for the fiscal quarter ended September 30, 2008, decreased by 10.7% to $9.6 million from $10.8 million for the same period in the previous year due to fluctuations in our capacity and customer orders.

Cost of Sales

Cost of sales for the fiscal quarter ended September 30, 2008, including product recall related expenses and purchases from third-party producers, increased by 207.0% to $121.5 million from $39.6 million for the same period in the previous year.

Cost of sales for our nutritional products for the fiscal quarter ended September 30, 2008 increased by 257.1% to $112.8 million from $31.6 million for the same period in the previous year. The significant increase in the cost of sales is due primarily to the increase of the product recall related cost, partially offset by the decrease in the sales volume of our nutritional products. The portion of the estimated product recall cost, which has been recognized as cost of sales for the fiscal quarter ended September 30, 2008, was $75.5 million, reflecting the cost of recalled products and the write-down and write-off of affected inventory. Sales volume of nutritional products sold for the fiscal quarter ended September 30, 2008 decreased by 771 tons as compared to the same period in the previous year.

Cost of sales for our other products and services for the fiscal quarter ended September 30, 2008 increased by 9.0% to $8.7 million from $8.0 million for the same period in the previous year due to rising raw material costs.

Gross Profit (Loss)

As a result of the foregoing, we recorded a gross loss of $26.7 million for the fiscal quarter ended September 30, 2008, as compared to a gross profit of $46.6 million for the same period in the previous year. Gross loss for our nutritional products for the fiscal quarter ended September 30, 2008 was $27.7 million, as compared to gross profit of $43.8 million for the same period in the previous year primarily due to the estimated costs associated with the product recall including write-down and write-off of affected inventories.

Selling and Distribution Expenses

Selling and distribution expenses for the fiscal quarter ended September 30, 2008 increased by 28.2% to $10.7 million from $8.3 million for the same period in the previous year. This increase was primarily a result of increased compensation expenses for our sales force, and an increase in shipping and handling expenses as well as travel and entertainment expenses. Total compensation for our sales force for the fiscal quarter ended September 30, 2008 increased by 47.3% to $4.7 million from $3.2 million for the same period in the previous year. This increase was primarily due to the continuation of our targeted sales incentive programs. In addition, the increase in the number of sales staff to 2,809 as of September 30, 2008 from 2,111 as of September 30, 2007 also contributed to the increase in compensation expense relating to our sales force. The portion of the estimated product recall cost, which was recognized as selling and distribution expenses for the fiscal quarter ended September 30, 2008 was $1.9 million, reflecting shipping and handling expenses for the recalled products. As a result of the product recall and business expansion, shipping and handling expenses for the fiscal quarter ended September 30, 2008 increased by 101.1% to $2.9 million from $1.5 million for the same period in the previous year. Travel and entertainment expenses for the fiscal quarter ended September 30, 2008 increased by 48.4% to $1.6 million from $1.1 million for the same period in the previous year.

Advertising and Promotion Expenses

Advertising and promotion expenses for the fiscal quarter ended September 30, 2008 decreased by 15.3% to $18.6 million from $22.0 million for the same period in the previous year. Advertising expenses for the fiscal quarter ended September 30, 2008, which accounted for 68.2% of total advertising and promotion expenses, increased by 22.3% to $12.7 million from $10.4 million for the same period in the previous year, due primarily to our continuously increased nationwide TV advertising. Promotion expenses for the fiscal quarter ended September 30, 2008, which accounted for 31.8% of total advertising and promotion expenses, decreased by 49.0% to $5.9 million from $11.6 million for the same period in the previous year, due primarily to the disruption of sales promotion activities at retail stores in the aftermath of the melamine contamination incident.

General and Administrative Expenses

General and administrative expenses for the fiscal quarter ended September 30, 2008 increased by 85.2% to $6.8 million from $3.7 million for the same period in the previous year. The increase in general and administrative expenses was due primarily to increased legal and professional expenses associated with our cancelled public offering, increased office expenses and increased depreciation and amortization expenses.

Interest Income

Interest income for the fiscal quarter ended September 30, 2008 decreased to $186,000 from $0.8 million for the same period in the previous year due to decreased bank deposits.

Interest Expense

Interest expense for the fiscal quarter ended September 30, 2008 decreased to $545,000 from $2.6 million for the same period in the previous year, due primarily to the amortization of debt discount associated with the issuance of warrants to ABN which amounted to $1.3 million in the fiscal quarter ended September 30, 2007, and lower average loan balances outstanding during the fiscal quarter ended September 30, 2008.

Provision (Benefit) for Income Tax

As a result of the net loss arising primarily from the estimated cost of the product recall including the write-down and write-off of affected inventory, we recorded an income tax credit of $12.7 million for the fiscal quarter ended September 30, 2008, as compared to an income tax provision of $1.3 million for the fiscal quarter ended September 30, 2007.

Net Income (Loss) Attributable to Stockholders

As a result of the foregoing, net loss attributable to stockholders for the fiscal quarter ended September 30, 2008 was $49.7 million, as compared to net income of $9.8 million for the same period in the previous year.

Six months ended September 30, 2008 and 2007

Net Sales

Net sales for the six months ended September 30, 2008 increased by 44.6% to $222.2 million from $153.7 million for the same period in the previous year. This increase in net sales was a combined result of increased sales from April to August 2008, partially offset by decreased sales in September 2008 due to the disruption of our operations caused by the melamine contamination incident.

Net sales of our nutritional products, including infant formula and other nutritional products for children and adults under our Super, U-Smart, U-Strong brand names, accounted for 91.5% of our total sales for the six months ended September 30, 2008. Net sales of our nutritional products for the six months ended September 30, 2008 increased by 52.6% to $203.2 million from $133.2 million for the same period in the previous year, primarily as a result of the following factors:

n Sales volume of nutritional products increased by 23.6% to 21,864 tons for the six months ended September 30, 2008 from 17,696 tons for the same period in the previous year. The increase was primarily due to the significant business growth experienced in the months from April to August and partially offset by the decreased sales in the second half of September due to the melamine contamination incident.

n The average selling price of our nutritional products for the six months ended September 30, 2008 increased by 23.5% to $9,295 per ton from $7,528 per ton for the same period in the previous year. This increase in average selling price was primarily due to an increase in sales of Super infant formula products, which resulted in a greater proportion of higher-priced products in our product mix.

Net sales from our other activities, such as sales of industrial materials and the provision of certain services, such as toll drying, blending and packaging services, for the six months ended September 30, 2008 decreased by 7.5% to $18.9 million from $20.5 million for the same period in the previous year due to fluctuations in our capacity and customer orders.

Cost of Sales

Cost of sales for the six months ended September 30, 2008, including product recall related expenses and purchases from third-party producers, increased by 160.0% to $182.0 million from $70.0 million for the same period in the previous year.

Cost of sales for our nutritional products for the six months ended September 30, 2008 increased by 209.7% to $165.1 million from $53.3 million for the same period in the previous year. The significant increase in the cost of sales is due primarily to the increase of the product recall related cost and the increase in the sales volume of our nutritional products. The portion of the estimated product recall cost, which has been recognized as cost of sales for the fiscal quarter ended September 30, 2008, was $75.5 million, reflecting the cost of recalled products and the write-down and write-off of affected inventory. The sales volume of nutritional products sold for the six months ended September 30, 2008 increased by 4,168 tons as compared to the same period in the previous year.

Cost of sales for our other products and services for the six months ended September 30, 2008 increased by 1.0% to $16.9 million from $16.7 million for the same period in the previous year due to an increase in raw material costs.

Gross Profit (Loss)

As a result of the foregoing, gross profit for the six months ended September 30, 2008 decreased by 52.0% to $40.2 million from $83.7 million for the same period in the previous year. Gross profit for our nutritional products for the six months ended September 30, 2008 decreased by 52.3% to $38.2 million from $79.9 million for the same period in the previous year due primarily to the estimated costs in relation to product recall including the write-down and write-off of affected inventory.

Our overall gross margin decreased to 18.1% for the six months ended September 30, 2008 from 54.5% for the same period in the previous year. Our gross margin for nutritional products and other products was 18.8% and 10.7%, respectively, for the six months ended September 30, 2008, as compared to 60.0% and 18.4%, respectively, for the same period in the previous year.

The decrease in our gross margin for nutritional products was primarily due to the estimated cost of the product recall, partially offset by an increase in the proportion of sales of our higher margin infant formula products.

Selling and Distribution Expenses

Selling and distribution expenses for the six months ended September 30, 2008 increased by 39.0% to $22.1 million from $15.9 million for the same period in the previous year. This increase was primarily a result of increased compensation expenses for our sales force, and an increase in shipping and handling expenses as well as travel and entertainment expenses. Total compensation for our sales force for the six months ended September 30, 2008 increased by 75.7% to $9.8 million from $5.6 million for the same period in the previous year. This increase was primarily due to the continuation of our targeted sales incentive programs. In addition, the increase in the number of . . .